Financial News
Biotech ETFs Tracking CRISPR Gene Editing Surge
December 21, 2020 at 15:33 PM EST
A biotechnology exchange traded fund focusing on CRISPR gene editing bucked the broader market trends on Monday. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) advanced 7.1%. The ARK Genomic Revolution ETF tracks the convergence of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
